Date
8-11-2021 12:35 PM
Abstract
Silver has been known to be an antimicrobial for hundreds of years, but wasn’t thought to be useful in the medical field until the 1960’s. In more recent years people have been designing different methods of synthesis for silver nanoparticles, yet none of these methods prevent the oxidized silver (Ag+), which is toxic. As the use of silver nano materials for antimicrobial activity has expanded there has been an increase in interest in the medical field, and how silver nanoparticles can be used as an antimicrobial without having toxic effects. While there is a large availability of silver nanoparticles (AgNp’s) design strategies for controlling the rate of release of Ag+ is not well defined. Having well defined design strategies for release rate can help provide control for items that need both slow and quick release such as mesh, bandages, catheters, and other medical tubing. Consequently, there is a gap in our understanding of how to control the release rate of silver for the purpose of controlled release of Ag+, and therefore be stabilized and used for a range of antimicrobial applications. Because of the critical need for non-toxic antimicrobial agents that can target and kill bacteria in medical implants such as mesh and tubing, this study is of significant interest. With the increased interest in nanoparticles as an antimicrobial this has led us to the research question: How does surface chemistry affect the antimicrobial abilities of AgNp’s? Within this question we have a subset of questions this research should be able to answer; Can the AgNp’s successfully kill without releasing silver? How does shape and size affect the killing ability of the nanoparticles? How does varying Ag+ release rate affect killing ability?
Biographies
Alexandria Murphy, Biology
Alexandria Murphy is majoring in biology. She is a part of the Bartlett Lab and Mackiewicz Lab research team at Portland State University. She is currently a McNair Scholar and SSTEM Scholar. Her research interests include medicine delivery and design as well as gene targeting. She will begin pursuing her Ph.D. in biochemistry and molecular biology in the Fall of 2022.
Dr. Marilyn Mackiewicz Faculty Mentor | Assistant Chemistry Professor at OSU
Dr. Marilyn Mackiewicz is an assistant chemistry professor at Oregon State University. Mackiewicz received her PhD in Chemistry in 2005 from Texas A&M University. Prior to teaching and doing research at OSU, Mackiewicz was a research assistant professor at Portland State University for 11 years. Mackiewicz’s research focuses on the various uses of nanomaterials in biomedical, environmental, and commercial applications.
Dr. Michael Bartlett Faculty Mentor | Department of Biology
Dr. Bartlett received his Ph.D. in Cellular and Molecular Biology from the University of Wisconsin-Madison in 1997. He was then an NIH postdoctoral researcher at the University of California, San Diego, and joined the Portland State University biology faculty in 2002. His research concerns the function of basal transcription factors and RNA polymerase from the Archaeal domain and has been funded by the American Heart Association and the National Institutes of Health.
Disciplines
Biology
Rights
© Copyright the author(s)
IN COPYRIGHT:
http://rightsstatements.org/vocab/InC/1.0/
This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).
DISCLAIMER:
The purpose of this statement is to help the public understand how this Item may be used. When there is a (non-standard) License or contract that governs re-use of the associated Item, this statement only summarizes the effects of some of its terms. It is not a License, and should not be used to license your Work. To license your own Work, use a License offered at https://creativecommons.org/
Persistent Identifier
https://archives.pdx.edu/ds/psu/36197
Included in
Hybrid-lipid Coated Silver Nanoparticles as an Antimicrobial
Silver has been known to be an antimicrobial for hundreds of years, but wasn’t thought to be useful in the medical field until the 1960’s. In more recent years people have been designing different methods of synthesis for silver nanoparticles, yet none of these methods prevent the oxidized silver (Ag+), which is toxic. As the use of silver nano materials for antimicrobial activity has expanded there has been an increase in interest in the medical field, and how silver nanoparticles can be used as an antimicrobial without having toxic effects. While there is a large availability of silver nanoparticles (AgNp’s) design strategies for controlling the rate of release of Ag+ is not well defined. Having well defined design strategies for release rate can help provide control for items that need both slow and quick release such as mesh, bandages, catheters, and other medical tubing. Consequently, there is a gap in our understanding of how to control the release rate of silver for the purpose of controlled release of Ag+, and therefore be stabilized and used for a range of antimicrobial applications. Because of the critical need for non-toxic antimicrobial agents that can target and kill bacteria in medical implants such as mesh and tubing, this study is of significant interest. With the increased interest in nanoparticles as an antimicrobial this has led us to the research question: How does surface chemistry affect the antimicrobial abilities of AgNp’s? Within this question we have a subset of questions this research should be able to answer; Can the AgNp’s successfully kill without releasing silver? How does shape and size affect the killing ability of the nanoparticles? How does varying Ag+ release rate affect killing ability?